Yesterday, Kite Pharma Inc (NASDAQ:KITE) impressed at the 2017 American Association of Cancer Research annual meeting, presenting an encouraging full six- month data …
Kite Pharma Inc (NASDAQ:KITE) shares are on the run, after the drug maker announced the much-awaited top line results from its Phase 2 ZUMA-1 …
Global Blood Therapeutics Inc (NASDAQ:GBT) shares rose about 9% today after the biopharmaceutical company initiated a Phase 1 trial evaluating GBT440 in healthy volunteers under hypoxic …
During last week’s American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, bluebird bio Inc (NASDAQ:BLUE) provided clinical updates on …
Roth Capital analyst Mark Breidenbach is out today with a favorable report on shares of Global Blood Therapeutics Inc (NASDAQ:GBT), after the company provided updated …
In a research report issued today, H.C.
H.C.
In a research report released today, H.C.
Vical Incorporated (NASDAQ:VICL) shares are tumbling 42.85% to $0.